PT1206248E - Composicoes sedativo-hipnoticas de libertacao controlada e metodos relacionados com os mesmos - Google Patents

Composicoes sedativo-hipnoticas de libertacao controlada e metodos relacionados com os mesmos

Info

Publication number
PT1206248E
PT1206248E PT00961399T PT00961399T PT1206248E PT 1206248 E PT1206248 E PT 1206248E PT 00961399 T PT00961399 T PT 00961399T PT 00961399 T PT00961399 T PT 00961399T PT 1206248 E PT1206248 E PT 1206248E
Authority
PT
Portugal
Prior art keywords
sedative
hypnotic
compound
same
methods related
Prior art date
Application number
PT00961399T
Other languages
English (en)
Inventor
D Bruce Campbell
W Jay Thiele
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of PT1206248E publication Critical patent/PT1206248E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT00961399T 1999-08-26 2000-08-28 Composicoes sedativo-hipnoticas de libertacao controlada e metodos relacionados com os mesmos PT1206248E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38444899A 1999-08-26 1999-08-26

Publications (1)

Publication Number Publication Date
PT1206248E true PT1206248E (pt) 2003-11-28

Family

ID=23517364

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00961399T PT1206248E (pt) 1999-08-26 2000-08-28 Composicoes sedativo-hipnoticas de libertacao controlada e metodos relacionados com os mesmos

Country Status (9)

Country Link
EP (2) EP1352647A1 (pt)
JP (1) JP2003507413A (pt)
AT (1) ATE241968T1 (pt)
AU (1) AU7335500A (pt)
DE (1) DE60003194T2 (pt)
DK (1) DK1206248T3 (pt)
ES (1) ES2199857T3 (pt)
PT (1) PT1206248E (pt)
WO (1) WO2001013895A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
AU2004273830B2 (en) * 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
US20070020333A1 (en) * 2005-07-20 2007-01-25 Chin-Chih Chiang Controlled release of hypnotic agents
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
WO2011102506A1 (ja) * 2010-02-22 2011-08-25 第一三共株式会社 経口用徐放性固形製剤
EP2540318B1 (en) 2010-02-22 2018-10-24 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
CN102670613A (zh) * 2011-03-16 2012-09-19 中国人民解放军军事医学科学院毒物药物研究所 用于改善茚地普隆溶出的药物组合物及其制备方法
CN104768552A (zh) 2012-09-03 2015-07-08 第一三共株式会社 含有盐酸氢吗啡酮的口服持续释放药物组合物
NZ720813A (en) * 2014-02-06 2021-12-24 Lan Bo Chen Composition and method for aiding sleep

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654347A (en) * 1983-06-23 1987-03-31 American Cyanamid Company Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4948592A (en) * 1986-05-09 1990-08-14 Alza Corporation Pulsed drug delivery
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US6472528B1 (en) * 1999-08-10 2002-10-29 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines

Also Published As

Publication number Publication date
DK1206248T3 (da) 2003-09-29
ATE241968T1 (de) 2003-06-15
EP1352647A1 (en) 2003-10-15
DE60003194D1 (de) 2003-07-10
WO2001013895A3 (en) 2001-09-27
WO2001013895A2 (en) 2001-03-01
EP1206248B1 (en) 2003-06-04
JP2003507413A (ja) 2003-02-25
DE60003194T2 (de) 2004-06-17
ES2199857T3 (es) 2004-03-01
EP1206248A2 (en) 2002-05-22
AU7335500A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
GB9911762D0 (en) Chemical compounds
BR9916835A (pt) Composição de galantamina de liberação controlada
BG106586A (en) Pyrazolopyramidines as therapeutic agents
ID27178A (id) Senyawa aminosikloheksil eter dan penggunaannya
PA8494101A1 (es) Derivados heterociclicos utiles como agentes anticancerosos
BR9916772A (pt) Quinolinacarboxamidas como agentes antivirais
LU91854I2 (fr) Eribulin et ses dérivés pharmaceutiquement acceptables (HALAVEN®)
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SG165162A1 (en) Modified release pharmaceutical formulation
BR0014902A (pt) Formulações orais para compostos antitumorais
PT1206248E (pt) Composicoes sedativo-hipnoticas de libertacao controlada e metodos relacionados com os mesmos
EP1222922A4 (en) METHOD FOR STABILIZING BENZIMIDAZOLE COMPOUNDS
HUP0100024A2 (hu) Alzheimer-kór kezelésére szolgáló hatóanyagként karvedilolszármazékokat tartalmazó gyógyszerkészítmények
EP1277744A4 (en) OXADIAZONE DERIVATIVES WITH ANTIBODY EFFECT
DK0570294T3 (da) 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel
IL136100A0 (en) Biphenylamidine derivatives, prodrugs thereof and pharmaceutical compositions containing the same
BRPI9916820A2 (pt) Formulações farmacêuticas
TR200200550T2 (tr) Piruvat dehidrojenaz aktivitesini yükselten ikameli n-fenil 2-hidroksi -2- metil -3,3,3- triflüoropropanamid türevleri.
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
EP1061070A4 (en) 24-hydroxy vitamin D derivatives
AU4609701A (en) Colouring agent for keratin containing fibres
ES2123038T3 (es) Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
AR042571A1 (es) L-arabino disacaridos de antraciclinas, sus procesos de preparacion y composiciones farmaceuticas que los contienen y su uso para la preparacion de composisiones farmaceuticas
HUT48615A (en) Process for producing dibenzo/b, e/oxepinacetic acid derivatives and pharmaceutical compositions comprising such compounds